My Cart

Recombinant Monoclonal Anti-CD99 Antibody, Rabbit (4F5)

Customer Reviews
Cat. No. / Size
Price
Qty
HGS-S263-20ul
$140.00
HGS-S263-100ul
$485.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Background

    Recombinant Monoclonal Anti-CD99 Antibody, Rabbit (4F5) is a CD99 primary antibody for IHC application. Involved in T-cell adhesion processes and in spontaneous rosette formation with erythrocytes. Plays a role in a late step of leukocyte extravasation helping leukocytes to overcome the endothelial basement membrane. Acts at the same site as, but independently of, PECAM1. Involved in T-cell adhesion processes (By similarity).

  • Product Specifications

    Host Species
    Rabbit
    Isotype
    Rabbit IgG, Rabbit Kappa
    Clone
    4F5
    Application
    IHC-P
    Dilution Ratio
    1: 500 - 1: 2000
    Form
    Liquid
    Clonality
    Monoclonal
    Reactivity
    Human
    Synonyms
    MIC2
    Concentration
    0.9~1.1 mg/ml
    Specificity
    React with CD99 protein on the membrane of target cell/tissue
    Purification Tech
    Protein A
    Preservation
    PBS, BSA, Glycerol
  • Experiment Protocol

    LEICA Experiment Protocol

  • Storage

    Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
    Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Sample Staining Data

     CD99 SAMPLE STAINING DATA
  •  CD99 SAMPLE STAINING DATA

    Immunohistochemical analysis of paraffin embedded human cancer tissue labelled with HGS-S263 at 1/1000 dilution.
    Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Development Progress
  • English Name:

    CD99 antigen

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    1 Details

  • Highest Development Stage:

    Phase 2 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland